Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public Healthcare
- PMID: 40690104
- DOI: 10.1007/s11892-025-01599-x
Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public Healthcare
Abstract
Purpose of review: In this review, we explore the under-recognized burden of fractures in diabetes, focusing on resource-constrained healthcare systems. We examine the epidemiology, assessment methodologies, and management approaches to osteoporosis in diabetes and discuss strategies to improve skeletal health outcomes.
Recent findings: Public healthcare strategies for fracture risk reduction in diabetes include educating healthcare providers, empowering patients, and integrating fracture liaison services for secondary prevention. Community-based awareness programs, digital health solutions, and screening tools such as FRAX® (with diabetes-specific adjustments) facilitate early identification and management. Policies supporting insurance coverage and cost-effective management strategies are likewise crucial. Diabetes-related bone fragility, characterized by altered bone quality and increased fracture risk despite relatively preserved bone density, creates a significant yet underrecognized health burden. Fracture prevention in diabetes is both a clinical necessity and an economic imperative. In this expanding cohort, multidisciplinary, policy-supported strategies can reduce morbidity, mortality, and costs associated with fragility fractures.
Keywords: Diabetes; Fracture liaison services, cost-effectiveness; Fracture prevention; Osteoporosis; Public healthcare.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Human and Animal Rights: This article does not contain any studies with human or animal subjects performed by any of the authors. Disclosures: The views and opinions expressed are solely those of the authors and do not represent or reflect those of any affiliated institutions.
Similar articles
-
The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.Health Technol Assess. 2007 Feb;11(4):1-134. doi: 10.3310/hta11040. Health Technol Assess. 2007. PMID: 17280622
-
A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.Arch Osteoporos. 2016 Dec;11(1):25. doi: 10.1007/s11657-016-0278-z. Epub 2016 Jul 27. Arch Osteoporos. 2016. PMID: 27465509 Free PMC article.
-
A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.Health Technol Assess. 2016 Oct;20(78):1-406. doi: 10.3310/hta20780. Health Technol Assess. 2016. PMID: 27801641 Free PMC article.
-
Biases in the performance of FRAX without BMD in predicting fracture risk in a multiethnic population with diabetes: the Diabetes and Aging Study.J Bone Miner Res. 2025 Apr 21;40(4):478-491. doi: 10.1093/jbmr/zjaf012. J Bone Miner Res. 2025. PMID: 39876767
-
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.Health Technol Assess. 2005 Jun;9(22):1-160. doi: 10.3310/hta9220. Health Technol Assess. 2005. PMID: 15929857
References
-
- Starup-Linde J, Frost M, Vestergaard P, Abrahamsen B. Epidemiology of fractures in diabetes. Calcif Tissue Int. 2017;100(2):109–21. - PubMed
-
- Wu B, Fu Z, Wang X, Zhou P, Yang Q, Jiang Y, et al. A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment. Front Endocrinol. 2022;14(13):1052592.
-
- Chandran M, Aftab N, Amin A, Amphansap T, Bhadada SK, Chadha M, et al. Evaluating compliance with the care standard of proactively assessing bone health in patients with diabetes: a pilot audit of practice across Asia by the Asia Pacific Consortium on Osteoporosis (APCO). Arch Osteoporos. 2024;19(1):48. - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials